Company / Current Liabilities per Share
Immunovant, Inc. Current Liabilities per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.32
FY2024
5-year range
$0.17 / $0.36
FY2020-FY2024
Trend
+2.3%
vs FY2023
Sector context
#179 of 212
Health Care
What the data says
Immunovant, Inc.'s current liabilities per share of $0.32 is lower than 84% of companies in the Health Care sector (FY2024). Current Liabilities per Share has fluctuated over the past 5 years, ranging from $0.17 in FY2021 to $0.36 in FY2022.
Based on SEC 10-K filings.
0.32 in FY2024 with a 3-year CAGR of +23.3%.
Improved from $0.36 to $0.32 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +23.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-97.9% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share increased 2.3% year-over-year.
- Ranks #179 out of 212 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2022.
- Lowest current liabilities per share in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.32 | +2.3% |
| FY2023 | $0.31 | -13.3% |
| FY2022 | $0.36 | +111.4% |
| FY2021 | $0.17 | -2.0% |
| FY2020 | $0.17 | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026